Financings in Brief: Medical Device Technologies Inc.
This article was originally published in The Gray Sheet
Executive Summary
Medical Device Technologies Inc.: Firm's registration statement relating to a secondary offering of 6% cumulative convertible series A preferred stock is declared effective by SEC. Medical Device Technologies, developer of the Personal Alarm System, offers 1.5 mil. shares of preferred stock for $5 per share, and 1.5 mil. redeemable warrants for 10 [cents] each. Preferred shares in the offering are convertible to four shares of common stock at a conversion price of $1.25 per share; the warrants are exercisable for two shares of common stock for an aggregate price of $3.75. Prior to the offering, Medical Device Technologies enacted a one-for-two reverse stock split of its common shares on June 21...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.